Does Dr. JEREMY ABRAMSON have financial conflicts of interest?

Dr. JEREMY ABRAMSON (MD) has received a total of $274,547 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $251,250 in personal promotional payouts (consulting, meals, travel) and $23,297 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JEREMY ABRAMSON?

According to CMS Open Payments data, Dr. JEREMY ABRAMSON received funding from E.R. SQUIBB & SONS, L.L.C ($48,207), F. HOFFMANN-LA ROCHE AG ($41,160), and GENENTECH ($33,061).

Does Dr. JEREMY ABRAMSON receive research grants or speaking fees?

Dr. JEREMY ABRAMSON has received $251,250 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $23,297 in clinical research grants.

DR. JEREMY ABRAMSON

MDReal-Time Hydrated

Specialty: Internal Medicine, Medical Oncology

Practice Location: BOSTON, MA 02114

NPI Number: 1740262484

LIFETIME INDUSTRY VALUE

$274,547

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ABRAMSON is a verified Internal Medicine, Medical Oncology practitioner based in BOSTON, MA.

Between 2021 and 2025, Dr. ABRAMSON had an overall industry promotional and research financial footprint of $274,547 as recorded in the federal CMS Open Payments database.

$251,250 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$23,297 was allocated to sponsored clinical trials and medical research activities.

Dr. ABRAMSON's primary funding source is E.R. SQUIBB & SONS, L.L.C, which accounts for $48,207 (representing 17.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

E.R. SQUIBB & SONS, L.L.C

Rank 1

$48,207

17.6%

F. HOFFMANN-LA ROCHE AG

Rank 2

$41,160

15%

GENENTECH

Rank 3

$33,061

12%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.